Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms
Inflammation · 2024
DOI: 10.1007/s10753-024-02085-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Fredrika Wannberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Division of Internal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Neoplasms, Inflammation, Histones, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet Research Internship, Jochnick Foundation, The Swedish Research Council.
Abstract (Originalsprache)
Cancer detection is challenging, especially in patients with unspecific cancer symptoms. Biomarkers could identify patients at high risk of cancer. Prior studies indicate that neutrophil extracellular traps (NETs) are associated with cancer, but also with autoimmune and infectious diseases. The objective of this prospective study was to investigate markers associated with NET formation (nucleosomal citrullinated histone 3 [H3Cit-DNA], cell free DNA [cfDNA] and neutrophil elastase [NE]), and c-reactive protein (CRP) in patients with unspecific cancer symptoms, such as fatigue, weight loss or radiological sign of malignancy without an apparent primary tumor, referred to the Diagnostic Center at Danderyd Hospital in Sweden. Blood samples were drawn on admission, before cancer diagnosis. Out of 475 patients, 160 (34%) were diagnosed with cancer, 56 (12%) with autoimmune disease, 32 (7%) with infectious disease, 71 (15%) with other diseases and 156 (33%) received no diagnosis. H3Cit-DNA, cfDNA, NE and CRP were significantly higher in patients with cancer compared to patients without cancer ( p < 0.0001, p < 0.0001, p = 0.004, and p = 0.0002 respectively). H3Cit-DNA, but not cfDNA, NE or CRP, was significantly elevated in patients with cancer compared to patients with autoimmune disease ( p = 0.0001). H3Cit-DNA, cfDNA, NE or CRP did not differ between cancer and infectious disease. In conclusion, H3Cit-DNA is elevated in patients diagnosed with cancer compared to non-cancer patients with the same symptomatology. Further studies should evaluate if H3Cit-DNA could aid in selecting patients that would benefit the most from a rapid cancer diagnostic work-up. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Division of Internal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
- Division of Specialist Medical Care, Danderyd Hospital, Diagnostic Center, Stockholm, Sweden.
- Department of Medical Cell Biology, SciLifeLab, Uppsala University, Uppsala, Sweden.
- Department of Chemistry, University of Oxford, Oxford, UK.
- Department of Medical Sciences, Clinical Chemistry and SciLifeLab Affinity Proteomics, Uppsala University, Uppsala, Sweden.
- Division of Internal Medicine, Department of Clinical Sciences, Division of Orthopedics, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Förderung
- Karolinska Institutet Research Internship
- Jochnick Foundation
- The Swedish Research Council
- The Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet
- The Swedish Society of Medicine
- Karolinska Institute
Zitieren
APA
Wannberg, F., Hjalmar, V., Ng, H., Johansson, C., Probert, F., Phillipson, M., Åberg, M., Gordon, M., Mackman, N., Rosell, A., & Thålin, C. (2024). Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms. Inflammation. https://doi.org/10.1007/s10753-024-02085-4
Vancouver
Wannberg F, Hjalmar V, Ng H, Johansson C, Probert F, Phillipson M, et al. Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms. Inflammation. 2024. doi:10.1007/s10753-024-02085-4
BibTeX
@article{Wannberg2024,
author = {Wannberg, Fredrika and Hjalmar, Viktoria and Ng, Henry and Johansson, Caroline and Probert, Fay and Phillipson, Mia and Åberg, Mikael and Gordon, Max and Mackman, Nigel and Rosell, Axel and Thålin, Charlotte},
title = {Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms},
journal = {Inflammation},
year = {2024},
doi = {10.1007/s10753-024-02085-4}
}
EUVIMED